Pluri (PLUR) Change in Account Payables (2010 - 2025)
Pluri (PLUR) reported Change in Account Payables of $122000.0 for Q4 2025, up 771.43% year-over-year from $14000.0 in Q4 2024, and up 20.79% quarter-over-quarter from $101000.0 in Q3 2025.
Pluri (PLUR) Change in Account Payables (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Change in Account Payables data on file, last reported at $122000.0 in Q4 2025.
- Change in Account Payables for Q4 2025 came in at $122000.0, up 771.43% year-over-year; the trailing twelve-month figure through Dec 2025 was -$176000.0 (down 277.78% YoY), and the FY2025 annual result was -$235000.0, up 69.79% from the prior year.
- Change in Account Payables rose to $122000.0 in Q4 2025 per PLUR's latest filing, from $101000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $432000.0 in Q2 2021 and troughed at -$883000.0 in Q3 2023.
- A 5-year average of -$90850.0 and a median of -$10000.0 in 2024 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 771.43% in 2025 and fell as far as 1306.9% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $291000.0 in 2021, then slumped by 123.02% to -$67000.0 in 2022, then jumped by 353.73% to $170000.0 in 2023, then sank by 91.76% to $14000.0 in 2024, then surged by 771.43% to $122000.0 in 2025.
- Business Quant data shows PLUR's Change in Account Payables at $122000.0 in Q4 2025, $101000.0 in Q3 2025, and $9000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,000.00 |
| Dec 31, 2025 | 122,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | -408,000.00 |
| Mar 31, 2025 | -408,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | -36,000.00 |
| Jun 30, 2024 | -36,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Sep 30, 2023 | -883,000.00 |
| Sep 30, 2023 | -883,000.00 |